Epilepsy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with drug-resistant epilepsy diagnosis; 2. Patients with epilepsy at least once a month; 3. Patients taking medicine regularly at present; 4. Subjects aged 1-18 years old; 5. Subjects who did not consider other non drug treatment regimens in the past six months.
Exclusion criteria
Exclusion criteria: 1. Subjects who had been treated with other probiotics within 30 days before inclusion in the study; 2. Subjects with chronic gastrointestinal diseases, liver or renal insufficiency, lactose intolerance, diarrhea, immunosuppressive diseases, long-term use of antibiotics, and severe psychiatric diseases; 3. Subjects who have participated in other epilepsy treatment related studies within 3 months; 4. Subjects who cannot follow up regularly.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of seizure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intestinal flora analysis; | — |
Countries
China
Contacts
Neurology Department of Shenzhen Children's Hospital